Trials / Completed
CompletedNCT02543151
SpyGlass in Post Liver Transplant Biliary Complications.
Prospective Evaluation of SpyGlass Direct Visualization System in Post Liver Transplant Biliary Stricture.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hospital Israelita Albert Einstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe SpyGlass choledochoscopy in patients with post orthotopic liver transplant (OLT) biliary strictures prior to endoscopic therapy and ductal changes after treatment stents.
Detailed description
A prospective observational clinical study to be conducted in Hospital Israelita Albert Einstein, a large open-access, private tertiary referral center. Consecutive eligible patients with suspected post OLT biliary complications referred to endoscopic retrograde cholangiopancreatography (ERCP) will be considered to SpyGlass as follows. In those patients with confirmed biliary stricture, SpyGlass direct choledochoscopy will be performed prior to endoscopic treatment with stents. After final stent removal, choledochoscopy will be repeated to evaluate biliary ductal mucosa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | SpyGlass (direct visualization system) choledochoscopy | SpyGlass (direct visualization system) choledochoscopy procedure will be performed pre and post biliary complication treatment |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Completion
- 2018-10-01
- First posted
- 2015-09-07
- Last updated
- 2019-04-17
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02543151. Inclusion in this directory is not an endorsement.